98%
921
2 minutes
20
Background: Tuberculous pericarditis is the most common cause of pericardial disease in tuberculosis-endemic areas. Accurate and early diagnosis of tuberculous pericarditis is crucial due to its high mortality; however, the diagnostic accuracy of current methods remains suboptimal. This study aims to investigate the clinical application value and imaging characteristics of F-FDG PET/CT in tuberculous pericarditis.
Methods: A total of 11 patients with tuberculous pericarditis were retrospectively analyzed in this study. Patients were categorized into two groups based on the presence or absence of pericardial F-FDG uptake. Differences in clinical symptoms between the two groups were assessed using the Mann-Whitney U test. Additionally, all tuberculous lesions in lymph nodes and other organs within the scanning range were systematically evaluated.
Results: Tuberculous pericarditis was successfully detected by F-FDG PET/CT in 9 of the 11 patients, yielding a diagnostic sensitivity of 82%. Seven of these 9 patients exhibited diffuse pericardial F-FDG uptake on PET imaging, accompanied by lamellar pericardial thickening on CT. Two patients showed no pericardial F-FDG uptake. A significant difference was observed in the duration of symptoms prior to F-FDG PET/CT examination between patients with and without pericardial F-FDG uptake (Z=-2.15, P = 0.036). Specifically, patients without pericardial F-FDG uptake had a notably shorter symptom duration before undergoing F-FDG PET/CT (7 days/10 days vs. 40 (30,135) days). In this study, a total of 169 mediastinal lymphadenitis, 16 supraclavicular lymphadenitis, 1 cervical lymphadenitis, and 44 lymphadenitis in other areas were identified. Among the 11 patients, 7 exhibited intrapericardial tuberculosis involvement, primarily affecting the lungs and peritoneum.
Conclusions: F-FDG PET/CT demonstrated high sensitivity in the diagnosis of tuberculous pericarditis. The most common characteristic on F-FDG PET/CT was diffuse pericardial F-FDG uptake on PET accompanied by lamellar pericardial thickening on CT, which is indicative of tuberculous pericarditis. As a systemic examination, F-FDG PET/CT can also detect tuberculosis in other organs, providing complementary diagnostic information for tuberculous pericarditis, thereby facilitating the selection of a more appropriate biopsy site.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087193 | PMC |
http://dx.doi.org/10.1186/s12872-025-04828-z | DOI Listing |
J Cereb Blood Flow Metab
September 2025
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Preclinical PET studies offer the opportunity to elucidate molecular mechanisms underlying early neurodevelopment with minimal invasiveness. We demonstrated the feasibility of fetal brain PET in four pregnant rats ( = 42 fetuses). [F]FDG uptake in rat fetuses was readily visualized by PET imaging.
View Article and Find Full Text PDFNucl Med Biol
September 2025
Department of Nuclear Medicine, Hannover Medical School, Germany. Electronic address:
Purpose: The liver-brain axis regulates metabolic homeostasis, with glucose metabolism playing a key role. Liver dysfunction, such as fibrosis, may impact brain metabolism and consequently, brain function. Positron emission tomography (PET) imaging provides a non-invasive approach to study glucose metabolism in both organs.
View Article and Find Full Text PDFCancer Immunol Immunother
September 2025
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CHUV/UNIL, 1011, Lausanne, Switzerland.
Background: Immunotherapy is a mainstay in the treatment of patients with advanced melanoma. Yet, resistance mechanisms exist, and tumour-associated macrophages (TAMs), particularly the M2-like phenotype, are associated with poorer outcomes, with CD206 serving as their specific marker. We present the first human SPECT/CT study to visualize CD206 + TAMs in patients undergoing immunotherapy and compare the findings to clinical outcomes (NCT04663126).
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
September 2025
Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Purpose: Tebentafusp has emerged as the first systemic therapy to significantly prolong survival in treatment-naïve HLA-A*02:01 + patients with unresectable or metastatic uveal melanoma (mUM). Notably, a survival benefit has been observed even in the absence of radiographic response. This study aims to investigate the feasibility and prognostic value of artificial intelligence (AI)-assisted quantification and metabolic response assessment of [F]FDG long axial field-of-view (LAFOV) PET/CT in mUM patients undergoing tebentafusp therapy.
View Article and Find Full Text PDFMol Imaging Radionucl Ther
September 2025
University Clinical Center of Serbia, Center for Nuclear Medicine with PET, Belgrade, Serbia.
Fluorine-fluorocholine (F-FCH) is a radiopharmaceutical used in primary hyperparathyroidism. The data about its utility in malignancies other than prostate and hepatocellular carcinoma is limited. We present the case of a patient who was referred for F-FCH positron emission tomography/computed tomography (PET/CT) due to the persistently elevated parathormone and calcium levels following total thyroidectomy with left lower parathyroidectomy for parathyroid carcinoma (PTC).
View Article and Find Full Text PDF